Greater Irvine Chamber Welcomes Delegation of UK Life Science Companies
Wednesday, October 31, 2018
As part of its Foreign Direct Investment (FDI) initiative, the Greater Irvine Chamber last week hosted a three-day Irvine Lifescience Showcase for executives from 10 U.K. life science companies seeking expansion to the United States. The executives are from Forte Medical, Ampersand + Ampersand, Austin Fraser, Medical Realities, Plasticell, uMed, Innovarius, Cambridge Epigenetix, Kokoon, Performance Fifteen, and the Association of British HealthTech Industries.
The visiting executives joined more than 800 conference attendees at OCTANe’s Oct. 29-30 Medical Technology Innovation Forum (MTIF), which is focused on high-growth medical technology innovation and investment.
Linda DiMario, executive vice president of the Greater Irvine Chamber, who has spearheaded the FDI initiative, moderated a panel at MTIF outlining resources to build MedTech businesses in Southern California. Along with DiMario, were panelists Michael Seres, 11 Health; Mitch Wexler, Fragomen; Troy Varenchik, Deloitte Tax LLP; and Kevin Davidson, MemorialCare Health System.
The U.K. executives also had the opportunity to demonstrate their products and connect with medical technology professionals during the MTIF Innovation Showcase exhibition.
Monday’s itinerary concluded with a dinner for the delegates to meet with Irvine executives, Irvine Mayor Donald Wagner, and Greater Irvine Chamber President and CEO Bryan Starr.
The Showcase continues with one-on-one meetings with experts in taxes, legal, logistics, HR and talent acquisition, regulatory matters, real estate, and many other areas, providing the U.K. executives with resources to aid in doing business in Irvine.
For more information on foreign and domestic direct investment in Irvine/Orange County, contact Linda DiMario.
Category: Chamber News, Economic Development